跳至主要内容
临床试验/ISRCTN75392625
ISRCTN75392625已完成未知

A pilot clinical study of the effect of resveratrol on the serum level of Coll 2-1 and Aggrecan biomarkers in patients with knee osteoarthritis; a non-randomized open-labelled clinical trial

niversity of Sulaimani0 个研究点目标入组 35 人开始时间: 2020年9月9日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
35

研究概览

简要总结

2021 Results article in https://doi.org/10.1155/2021/3668568 (added 16/11/2021)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Mild to moderate OA at both screening and baseline visits, as defined by the up-to-date revised American College of Rheumatology (ACR) criteria for diagnosis of knee OA

排除标准

  • 1. Patients with a history of rheumatoid arthritis, gout, severe ischaemic heart disease, heart failure, hepatic failure, renal failure
  • 2. Consumption of non-steroidal anti-inflammatory drugs or corticosteroid drugs within 4 weeks of study, intra-articular injection within 3 months prior to the study recruitment
  • 3. Pregnant or desire to become pregnant, or lactating women

研究者

发起方
niversity of Sulaimani

相似试验